1. Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US. (2nd December 2018) Authors: Insinga, Ralph P.; Vanness, David J.; Feliciano, Josephine L.; Vandormael, Kristel; Traore, Sory; Burke, Thomas Journal: Journal of medical economics Issue: Volume 21:Number 12(2018) Page Start: 1191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US. (3rd July 2019) Authors: Insinga, Ralph P.; Vanness, David J.; Feliciano, Josephine L.; Vandormael, Kristel; Traore, Sory; Ejzykowicz, Flavia; Burke, Thomas Journal: Current medical research and opinion Issue: Volume 35:Number 7(2019) Page Start: 1241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost-effectiveness of pembrolizumab + chemotherapy versus chemotherapy and pembrolizumab monotherapy in first line treatment of NSCLC in the US – updated analyses with additional trial follow-up. (1st January 2021) Authors: Insinga, Ralph P.; Feliciano, Josephine L.; Qiao, Nan; Vandormael, Kristel; Zhang, Ying Journal: Journal of medical economics Issue: Volume 24:Number 1(2021) Page Start: 792 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. In response to She et al., "Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater". (August 2020) Authors: Huang, Min; Insinga, Ralph P.; Burke, Thomas; Zhang, Ying; de Lima Lopes, Gilberto Journal: Lung cancer Issue: Volume 146(2020) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗